Head of Platform Technologies MSAT Recombinant Mammalian Drug Substance CoE

Head of Platform Technologies, MSAT Recombinant Mammalian Drug Substance CoE

Framingham, MA

Sanofi Global MSAT (Manufacturing Sciences, Analytics, and Technology) acts as a crucial link between our R&D and Manufacturing facilities, playing a vital role in securing the present portfolio and delivering future launches of high-quality and innovative drugs and vaccines. By driving its own transformation, Global MSAT fulfils an important function by providing day-to-day Manufacturing Support, focusing on technical and process aspects, effective Life Cycle Management, process robustness enhancement, and yield improvement to optimize performance.

Join our global network and contribute to the launch of 3 to 5 new products annually across various modalities, enabling us to reach and serve more patients and communities. Collaborate with a team of talented and passionate international experts, scientists, and project leaders who are dedicated to inventing, designing, and implementing cutting-edge industrial chemical and biological processes, analytical methods, and process modelling, all in support of Sanofis best-in-class ambition.

The Head of Platform Technologies will lead a dynamic team of Subject Matter Experts within the MSAT Recombinant Mammalian Center of Excellence (CoE), located at Sanofis Massachusetts Framingham Bio-Campus. This team is responsible for establishing stateoftheart innovation laboratory infrastructures and enabling next generation platform technologies, including perfusion cell culture and continuous purification processes.

This senior leadership role will support implementation strategies for commercial programs by collaborating closely with R&D, Manufacturing, and external partners. The team will also spearhead global MSAT innovation initiatives across platforms in partnership with other MSAT groups, while representing MSATs scientific leadership and excellence in both internal and external forums.

We deliver 4.3 billion healthcare solutions to people every year, thanks to the flawless planning and meticulous eye for detail of our Manufacturing & Supply teams. With your talent and ambition, we can do even more to protect people from infectious diseases and bring hope to patients and their families.

Were an R&D-driven, AI-powered biopharma company committed to improving peoples lives and delivering compelling growth. Our deep understanding of the immune system and innovative pipeline enables us to invent medicines and vaccines that treat and protect millions of people around the world. Together, we chase the miracles of science to improve lives.

• Hybrid Schedule - 3 days per week onsite- required. *

• Lead the evaluation of Sanofis next generation platform technologies including perfusion cell culture, continuous purification, advanced Process Analytical Technology (PAT), smart manufacturing, and emerging novel process chemistries. Develop the MSAT position on development data package requirements, atscale operational readiness, transferability, labscale model expectations, and MSAT training and expertise needs. Ensure alignment of platform technology initiatives with broader organizational objectives such as 2ndgeneration program development, process robustness, and yield improvement.
• Establish and maintain cutting edge innovation laboratory infrastructures within the COE. Partner with upstream, downstream, and analytical teams to advance lab digitization and automation. Build additional laboratory and pilot scale capabilities that embody Sanofis smartlab future concept.
• Build and maintain strategic relationships with external partners and vendors. Oversee multiple collaboration projects with external…